During the past decade, Melmed Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Melmed Center" #1 sponsor was "Akili Interactive Labs, Inc." with 5 trials, followed by "Shire" with 3 trials sponsored, "Noven Therapeutics" with 2 trials sponsored, "Cephalon" with 1 trials sponsored and "Cognoa, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Melmed Center" #1 collaborator was "Nancy Lurie Marks Family Foundation" with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Melmed Center" are "ADHD" (5 trials), "Attention Deficit Hyperactivity Disorder" (3 trials), "Attention Deficit Disorder With Hyperactivity" (2 trials), "Autism Spectrum Disorder" (2 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials). Many other conditions were trialed in "Melmed Center" in a lesser frequency.

Most popular intervention types in "Melmed Center" are "Drug" (6 trials), "Device" (5 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AKL-T01" (3 trials), "Placebo" (3 trials), "ADHD Therapy" (1 trials), "AKL-T09" (1 trials) and "Cognoa ASD diagnostic device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Melmed Center" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Melmed Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Melmed Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Melmed Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".